{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T15:26:12Z","timestamp":1764084372215},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Loop diuretics are commonly used in clinical practice to manage high fluid loads and to control fluid balance. In this paper, a novel quantitative analysis method for multiple components with a single marker (QAMS) was developed for the simultaneous determination of 5 diuretic drugs furosemide, torasemide, azosemide, etacrynic acid, and bumetanide, by HPLC. Qualitative analysis was performed using relative retention time and ultraviolet (UV) spectral similarity as the double indicator. The QAMS method was conducted with etacrynic acid as an internal reference substance. The quantities of the other four diuretics were calculated by using the relative correction factors for etacrynic acid. The quantities of the 5 diuretic drugs were also determined by the external standard method (ESM). Chromatographic separation was achieved on a Shimadzu HC-C<jats:sub>18<\/jats:sub>column (150\u00a0mm\u2009\u00d7\u20094.6\u00a0mm, 5\u00a0\u00b5m) using 50\u00a0mM potassium dihydrogen phosphate (pH adjusted to 4.0 with phosphoric acid) with acetonitrile (64:36, v\/v) as the mobile phase at a flow rate of 1.0\u00a0mL\/min and a column temperature of 30\u00a0\u2103.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Under these conditions, the 5 diuretic drugs were well separated, showing linear relationships within certain ranges. The quantitative results showed that there was no significant difference between the QAMS and ESM methods.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Overall, the HPLC-QAMS analytical scheme established in this study is a simple, efficient, economical, and accurate method for the quantitative evaluation of 5 diuretic drugs.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13065-021-00764-z","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T16:04:43Z","timestamp":1623254683000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Simultaneous determination of five diuretic drugs using quantitative analysis of multiple components by a single marker"],"prefix":"10.1186","volume":"15","author":[{"given":"Fuchao","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoxia","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sicen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,9]]},"reference":[{"key":"764_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/1074248413497257","volume":"19","author":"GC Roush","year":"2014","unstructured":"Roush GC, Kaur R, Ernst ME (2014) Diuretics: a review and update. J Cardiovasc Pharmacol Ther 19:5\u201313","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"764_CR2","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1258\/acb.2011.011281","volume":"49","author":"D Wile","year":"2012","unstructured":"Wile D (2012) Diuretics: a review. Ann Clin Biochem 49:419\u2013431","journal-title":"Ann Clin Biochem"},{"key":"764_CR3","first-page":"1359","volume":"364","author":"SD Anisman","year":"2019","unstructured":"Anisman SD, Erickson SB, Morden NE (2019) How to prescribe loop diuretics in oedema. BMJ 364:1359","journal-title":"BMJ"},{"key":"764_CR4","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/anae.14038","volume":"73","author":"KT Ng","year":"2018","unstructured":"Ng KT, Jll Y (2018) Continuous infusion vs. intermittent bolus injection of furosemide in acute decompensated heart failure: systematic review and meta-analysis of randomised controlled trials. Anaesthesia 73:238\u2013247","journal-title":"Anaesthesia"},{"key":"764_CR5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S1388-9842(02)00122-8","volume":"4","author":"J Cos\u00edn","year":"2002","unstructured":"Cos\u00edn J, D\u00edez J (2002) Torasemide in chronic heart failure: results of the TORIC study. Eur J Heart Fail 4:507\u2013513","journal-title":"Eur J Heart Fail"},{"key":"764_CR6","doi-asserted-by":"publisher","first-page":"4469","DOI":"10.1111\/bph.13231","volume":"172","author":"K Lykke","year":"2015","unstructured":"Lykke K, T\u00f6llner K, Erker T (2015) Structure-activity relationships of bumetanide derivatives: correlation between diuretic activity in dogs and inhibition of the human NKCC2A transporter. Brit J Pharmacol 172:4469\u20134480","journal-title":"Brit J Pharmacol"},{"key":"764_CR7","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1097\/01.SMJ.0000082004.40613.D7","volume":"96","author":"JM Alisky","year":"2003","unstructured":"Alisky JM, Tuttle TF (2003) Ethacrynic acid can be effective for refractory congestive heart failure and ascites. South Med J 96:1148\u20131150","journal-title":"South Med J"},{"key":"764_CR8","doi-asserted-by":"publisher","first-page":"9877","DOI":"10.1038\/s41598-018-27995-w","volume":"8","author":"P Hampel","year":"2018","unstructured":"Hampel P, R\u00f6mermann K, MacAulay N (2018) Azosemide is more potent than bumetanide and various other loop diuretics to inhibit the sodium- potassium- chloride- cotransporter human variants hNKCC1A and hNKCC1B. Sci Rep 8:9877","journal-title":"Sci Rep"},{"key":"764_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jpha.2015.11.002","volume":"6","author":"L Zhang","year":"2015","unstructured":"Zhang L, Wang RL, Tian Y (2015) Determination of torasemide in human plasma and its bioequivalence study by high-performance liquid chromatography with electrospray ionization tandem mass spectrometry. J Pharm Anal 6:95\u2013102","journal-title":"J Pharm Anal"},{"key":"764_CR10","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.5740\/jaoacint.15-022","volume":"98","author":"M Stolarczyk","year":"2015","unstructured":"Stolarczyk M, Hubicka U, Krzek J (2015) Simultaneous determination of eight hypotensive drugs of various chemical groups in pharmaceutical preparations by HPLC-DAD. J AOAC Int 98:1542\u20131548","journal-title":"J AOAC Int"},{"key":"764_CR11","doi-asserted-by":"publisher","first-page":"633","DOI":"10.17344\/acsi.2014.1262","volume":"62","author":"V Subramanian","year":"2015","unstructured":"Subramanian V, Nagappan K, Mannemala S (2015) Optimization and validation of a sensitive method for HPLC-PDA simultaneous determination of torasemide and spironolactone in human plasma using central composite design. Acta Chim Slov 62:633\u2013641","journal-title":"Acta Chim Slov"},{"key":"764_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/chromsci\/39.10.425","volume":"39","author":"M Legorburu","year":"2001","unstructured":"Legorburu M, Alonso RM, Ortiz E (2001) Quantitative determination of the loop diuretic bumetanide in urine and pharmaceuticals by high-performance liquid chromatography with amperometric detection. J Chromatogr Sci 39:425\u2013530","journal-title":"J Chromatogr Sci"},{"key":"764_CR13","first-page":"2507","volume":"17","author":"CW Lin","year":"2011","unstructured":"Lin CW, Gonzalez P, Yuan F (2011) Cellular pharmacokinetic and pharmacodynamic analyses of ethacrynic acid: implications in topical drug delivery in the eye. Mol vis 17:2507\u20132515","journal-title":"Mol vis"},{"key":"764_CR14","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1136\/ejhpharm-2017-001264","volume":"25","author":"L Zah\u00e1lka","year":"2018","unstructured":"Zah\u00e1lka L, Klovrzov\u00e1 S, Matysov\u00e1 L, \u0160klubalov\u00e1 Z, Solich P (2018) Furosemide ethanol-free oral solutions for paediatric use: formulation HPLC method and stability study. Eur J Hosp Pharm 25:144\u2013149","journal-title":"Eur J Hosp Pharm"},{"issue":"10","key":"764_CR15","doi-asserted-by":"publisher","first-page":"e4304","DOI":"10.1002\/bmc.4304","volume":"32","author":"IA Naguib","year":"2018","unstructured":"Naguib IA, Abdelaleem EA, Emam AA, Ali NW, Abdallah FF (2018) Development and validation of HPTLC and green HPLC methods for determination of furosemide spironolactone and canrenone in pure forms tablets and spiked human plasma. Biomed Chromatogr 32(10):e4304","journal-title":"Biomed Chromatogr"},{"key":"764_CR16","first-page":"1210","volume":"33","author":"J Li","year":"2015","unstructured":"Li J, Guo Z, Zhao X, Han P, Feng S (2015) Simultaneous determination of four drugs for kidney diseases in urine by high performance liquid chromatography. Se pu 33:1210\u20131213","journal-title":"Se pu"},{"key":"764_CR17","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/bmc.3614","volume":"30","author":"I Baranowska","year":"2016","unstructured":"Baranowska I, P\u0142onka J (2016) Monitoring of biogenic amines and drugs of various therapeutic groups in urine samples with use of HPLC. Biomed Chromatogr 30:652\u2013657","journal-title":"Biomed Chromatogr"},{"issue":"11","key":"764_CR18","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.2116\/analsci.25.1307","volume":"25","author":"I Baranowska","year":"2009","unstructured":"Baranowska I, Markowski P, Baranowski J (2009) Development and validation of an HPLC method for the simultaneous analysis of 23 selected drugs belonging to different therapeutic groups in human urine samples. Anal Sci 25(11):1307\u20131313","journal-title":"Anal Sci"},{"key":"764_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/207028","volume":"2013","author":"I Youm","year":"2013","unstructured":"Youm I, Youan BBC (2013) Validated reverse-phase high-performance liquid chromatography for quantification of furosemide in tablets and nanoparticles. J Anal Methods Chem 2013:1\u20139","journal-title":"J Anal Methods Chem"},{"key":"764_CR20","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1039\/b802679c","volume":"133","author":"Z Zhang","year":"2008","unstructured":"Zhang Z, Wang D, Zhang L, Du M, Chen G (2008) Determination of diuretics in human urine by hollow fiber-based liquid\u2013liquid\u2013liquid microextraction coupled to high performance liquid chromatography. Analyst 133:1187\u20131194","journal-title":"Analyst"},{"key":"764_CR21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/157341111794815048","volume":"7","author":"Y Chen","year":"2011","unstructured":"Chen Y, Liu Y (2011) Analytical methods for the determination of anti-diuretic peptides in biological samples: challenges and perspectives. Curr Anal Chem 7:117\u2013129","journal-title":"Curr Anal Chem"},{"key":"764_CR22","doi-asserted-by":"publisher","first-page":"854","DOI":"10.3390\/molecules23040854","volume":"23","author":"Y Huan","year":"2018","unstructured":"Huan Y, Jie Z, Shang XY et al (2018) Multi-component analysis of Ilex Kudingcha C. J. Tseng by a single marker quantification method and chemometric discrimination of HPLC fingerprints. Molecules 23:854","journal-title":"Molecules"},{"key":"764_CR23","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.3390\/molecules24081521","volume":"24","author":"Y Li","year":"2019","unstructured":"Li Y, Zhang Y, Zhang Z, Hu Y, Cui X, Xiong Y (2019) Quality evaluation of Gastrodia elata tubers based on HPLC fingerprint analyses and quantitative analysis of multi-components by single marker. Molecules 24:1521","journal-title":"Molecules"},{"key":"764_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imr.2017.01.008","volume":"6","author":"C Zhu","year":"2017","unstructured":"Zhu C, Li X, Zhang B, Lin Z (2017) Quantitative analysis of multi- components by single marker-a rational method for the internal quality of Chinese herbal medicine. Integr Med Res 6:1\u201311","journal-title":"Integr Med Res"},{"issue":"3","key":"764_CR25","first-page":"799","volume":"17","author":"LH Chen","year":"2018","unstructured":"Chen LH, Wu Y, Guan YM, Jin C, Zhu WF, Yang M (2018) Analysis of the high-performance liquid chromatography fingerprints and quantitative analysis of multicomponents by single marker of products of fermented cordyceps sinensis. Comp Biochem Physiol 17(3):799\u2013803","journal-title":"Comp Biochem Physiol"},{"key":"764_CR26","doi-asserted-by":"publisher","first-page":"9194847","DOI":"10.1155\/2017\/9194847","volume":"2017","author":"S Wang","year":"2017","unstructured":"Wang S, Xu Y, Wang Y (2017) Simultaneous determination of six active components in Oviductus ranae via quantitative analysis of multicomponents by single marker. J Anal Methods Chem 2017:9194847","journal-title":"J Anal Methods Chem"},{"key":"764_CR27","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.talanta.2014.11.028","volume":"134","author":"CQ Wang","year":"2015","unstructured":"Wang CQ, Jia XH, Zhu S, Komatsu K, Wang X, Cai SQ (2015) A systematic study on the influencing parameters and improvement of quantitative analysis of multi-component with single marker method using notoginseng as research subject. Talanta 134:587\u2013595","journal-title":"Talanta"},{"issue":"5","key":"764_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jpha.2017.07.008","volume":"7","author":"A Chen","year":"2017","unstructured":"Chen A, Sun L, Yuan H, Wu A, Lu J, Ma S (2017) A holistic strategy for quality and safety control of traditional Chinese medicines by the \u201ciVarious\u201d standard system. J Pharm Anal 7(5):271\u2013279","journal-title":"J Pharm Anal"},{"key":"764_CR29","doi-asserted-by":"publisher","first-page":"5689","DOI":"10.2147\/DDDT.S279302","volume":"14","author":"FC Chen","year":"2020","unstructured":"Chen FC, He XD, Fang BX, Wang SC (2020) Simultaneous quantitative analysis of six proton-pump inhibitors with a single marker and evaluation of stability of investigated drugs in polypropylene syringes for continuous infusion use. Drug Des Dev Ther 14:5689\u20135698","journal-title":"Drug Des Dev Ther"},{"key":"764_CR30","unstructured":"ICH Expert Working Group (2005) Validation of analytical procedures: text and methodology Q2(R1). In: International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use, Geneva, Switzerland, pp 1\u201313"},{"issue":"11","key":"764_CR31","first-page":"1481","volume":"30","author":"Q Guo","year":"2019","unstructured":"Guo Q, Liu L, Zhou ZG, Qin Y (2019) Content determination of 7 related substances in solifenacin succinate raw material by HPLC with principal component self-control with correction factor. China Pharm 30(11):1481\u20131486","journal-title":"China Pharm"},{"issue":"11","key":"764_CR32","first-page":"1376","volume":"32","author":"QJ Yang","year":"2015","unstructured":"Yang QJ, Wang H, Gao YJ, Li JQ, Jiao JD, Quan QB, Chen JQ (2015) Application of substitution method of reference substance in the rapid determination of sedative drugs by HPLC. Chin J Mod Appl Pharm 32(11):1376\u20131381","journal-title":"Chin J Mod Appl Pharm"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-021-00764-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-021-00764-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-021-00764-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T13:15:17Z","timestamp":1672406117000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/s13065-021-00764-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,9]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["764"],"URL":"https:\/\/doi.org\/10.1186\/s13065-021-00764-z","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,9]]},"assertion":[{"value":"6 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there is no conflict of interests regarding the publication of this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}